News Focus
News Focus
Followers 36
Posts 3431
Boards Moderated 1
Alias Born 10/24/2015

Re: axelvento post# 14012

Saturday, 10/25/2025 4:23:57 PM

Saturday, October 25, 2025 4:23:57 PM

Post# of 14183
Data on mRNA-4359: ''The objective response rate was 24% in evaluable patients who received mRNA-4359 intramuscularly every three weeks for up to nine doses. Adding in patients with stable disease resulted in a 60% disease control rate. The trial is yet to reach the median duration of response.'' https://www.fiercebiotech.com/biotech/moderna-posts-melanoma-data-behind-decision-say-i-do-ido
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News